HomeQuestion

What systemic therapy would you suggest for metastatic odontogenic clear cell carcinoma with no actionable mutations on NGS?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?

Is there a scenario in which you would consider observation for T4a SCC involving the mandible?

How, if at all, are you modifying your practice and clinical workflow for patients receiving checkpoint inhibitors with data showing improved outcomes for patients receiving infusions earlier in the day?

How do you approach cisplatin dosing for locally advanced head and neck SCC in HPV-positive and HPV-negative patients?

In p16-positive oropharyngeal squamous cell carcinoma, when induction therapy is considered before definitive chemoradiation, how do you choose between a traditional TPF regimen and carboplatin/paclitaxel/pembrolizumab?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.